Skip to Main Content

Paper Details

PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology.
Breast
4
2022
Author NameAffiliation
Carmen CriscitielloEuropean Institute of Oncology IRCCS, Italy University of Milan
Alberto ZambelliHumanitas University, Italy IRCCS Humanitas Research Hospital
Caterina Marchi??Candiolo Cancer Institute FPO-IRCCS, University of Turin
  • 1 - 3

Datasets

Release 1.2